China genomics giant BGI targets A-share IPO

April 12, 2016

BGI, one of the world’s largest genome sequencing firms, plans to list in China to help fund growth and acquisitions but it is unclear if the IPO will see light in 2016. China genomics giant BGI targets A-share IPO

 

Source: FinanceAsia – Equity